ANGO – Angiodynamic Inc
Float Short %
9.56
Margin Of Safety %
Put/Call OI Ratio
0.13
EPS Next Q Diff
-0.06
EPS Last/This Y
0.52
EPS This/Next Y
0.22
Price
9.47
Target Price
18.25
Analyst Recom
1
Performance Q
0.43
Relative Volume
0.73
Beta
0.63
Ticker: ANGO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | ANGO | 9.22 | 0.13 | 0.07 | 4466 |
| 2025-07-28 | ANGO | 9.1 | 0.13 | 0.00 | 4467 |
| 2025-07-29 | ANGO | 9.14 | 0.13 | 0.07 | 4480 |
| 2025-07-30 | ANGO | 8.95 | 0.13 | 0.00 | 4504 |
| 2025-07-31 | ANGO | 8.86 | 0.13 | 2.52 | 4499 |
| 2025-08-01 | ANGO | 8.56 | 0.14 | 0.09 | 4530 |
| 2025-08-04 | ANGO | 8.68 | 0.15 | 0.00 | 4522 |
| 2025-08-05 | ANGO | 8.65 | 0.13 | 0.00 | 4885 |
| 2025-08-06 | ANGO | 8.4 | 0.13 | 0.31 | 4901 |
| 2025-08-07 | ANGO | 8.53 | 0.14 | 1.00 | 4865 |
| 2025-08-08 | ANGO | 8.52 | 0.13 | 0.03 | 4815 |
| 2025-08-11 | ANGO | 8.43 | 0.13 | 0.00 | 4795 |
| 2025-08-12 | ANGO | 8.85 | 0.12 | 0.00 | 4798 |
| 2025-08-13 | ANGO | 9.08 | 0.12 | 0.00 | 4745 |
| 2025-08-14 | ANGO | 8.72 | 0.12 | 1.00 | 4873 |
| 2025-08-15 | ANGO | 8.76 | 0.13 | 10.00 | 4895 |
| 2025-08-18 | ANGO | 8.78 | 0.09 | 0.55 | 3353 |
| 2025-08-19 | ANGO | 8.85 | 0.12 | 0.02 | 3680 |
| 2025-08-20 | ANGO | 9.11 | 0.13 | 0.32 | 3569 |
| 2025-08-21 | ANGO | 9.07 | 0.13 | 0.72 | 3539 |
| 2025-08-22 | ANGO | 9.47 | 0.13 | 0.01 | 3552 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | ANGO | 9.22 | -100.0 | - | -0.28 |
| 2025-07-28 | ANGO | 9.12 | -100.0 | - | -0.28 |
| 2025-07-29 | ANGO | 9.12 | -6.8 | - | -0.28 |
| 2025-07-30 | ANGO | 8.96 | -6.8 | - | -0.28 |
| 2025-07-31 | ANGO | 8.86 | -6.8 | - | -0.28 |
| 2025-08-01 | ANGO | 8.56 | -6.8 | - | -0.31 |
| 2025-08-04 | ANGO | 8.67 | -6.8 | - | -0.31 |
| 2025-08-05 | ANGO | 8.67 | -6.8 | - | -0.31 |
| 2025-08-06 | ANGO | 8.40 | -6.8 | - | -0.31 |
| 2025-08-07 | ANGO | 8.53 | -6.8 | - | -0.31 |
| 2025-08-08 | ANGO | 8.51 | -6.8 | - | -0.31 |
| 2025-08-11 | ANGO | 8.44 | -6.8 | - | -0.31 |
| 2025-08-12 | ANGO | 8.85 | -6.8 | - | -0.31 |
| 2025-08-13 | ANGO | 9.06 | -6.8 | - | -0.31 |
| 2025-08-14 | ANGO | 8.72 | -6.8 | - | -0.31 |
| 2025-08-15 | ANGO | 8.75 | -6.8 | - | -0.31 |
| 2025-08-18 | ANGO | 8.79 | -6.8 | - | -0.31 |
| 2025-08-19 | ANGO | 8.83 | -6.8 | - | -0.31 |
| 2025-08-20 | ANGO | 9.13 | -6.8 | - | -0.31 |
| 2025-08-21 | ANGO | 9.08 | -6.8 | - | -0.31 |
| 2025-08-22 | ANGO | 9.47 | -6.8 | - | -0.31 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | ANGO | 0.00 | 11.84 | 7.87 |
| 2025-07-28 | ANGO | 0.00 | 12.56 | 7.87 |
| 2025-07-29 | ANGO | 0.00 | 12.56 | 7.87 |
| 2025-07-30 | ANGO | 0.00 | 12.56 | 7.87 |
| 2025-07-31 | ANGO | 0.00 | 12.56 | 7.87 |
| 2025-08-01 | ANGO | 0.00 | 12.56 | 7.87 |
| 2025-08-04 | ANGO | 0.00 | 12.78 | 7.87 |
| 2025-08-05 | ANGO | 0.00 | 12.78 | 7.87 |
| 2025-08-06 | ANGO | 0.00 | 12.78 | 7.87 |
| 2025-08-07 | ANGO | 0.00 | 12.78 | 7.87 |
| 2025-08-08 | ANGO | 0.00 | 12.78 | 7.87 |
| 2025-08-11 | ANGO | 0.00 | 12.60 | 7.87 |
| 2025-08-12 | ANGO | 0.00 | 12.60 | 9.56 |
| 2025-08-13 | ANGO | 0.00 | 12.60 | 9.56 |
| 2025-08-14 | ANGO | 0.00 | 12.60 | 9.56 |
| 2025-08-15 | ANGO | 0.00 | 12.60 | 9.56 |
| 2025-08-18 | ANGO | 0.00 | 5.99 | 9.56 |
| 2025-08-19 | ANGO | 0.00 | 5.99 | 9.56 |
| 2025-08-20 | ANGO | 0.00 | 5.99 | 9.56 |
| 2025-08-21 | ANGO | 0.00 | 5.99 | 9.56 |
| 2025-08-22 | ANGO | 0.00 | 5.99 | 9.56 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.03
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
-0.09
Insider Transactions
Institutional Transactions
5.99
Beta
0.63
Average Sales Estimate Current Quarter
72
Average Sales Estimate Next Quarter
76
Fair Value
Quality Score
41
Growth Score
36
Sentiment Score
65
Actual DrawDown %
70.4
Max Drawdown 5-Year %
-83
Target Price
18.25
P/E
Forward P/E
PEG
P/S
1.31
P/B
2.12
P/Free Cash Flow
EPS
-0.83
Average EPS Est. Cur. Y
-0.31
EPS Next Y. (Est.)
-0.09
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-11.62
Relative Volume
0.73
Return on Equity vs Sector %
-43.3
Return on Equity vs Industry %
-27.4
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.07
EBIT Estimation
AngioDynamics, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 675
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
stock quote shares ANGO – Angiodynamic Inc Stock Price stock today
news today ANGO – Angiodynamic Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ANGO – Angiodynamic Inc yahoo finance google finance
stock history ANGO – Angiodynamic Inc invest stock market
stock prices ANGO premarket after hours
ticker ANGO fair value insiders trading